BHC
Price
$6.48
Change
+$0.02 (+0.31%)
Updated
Sep 26 closing price
Capitalization
2.4B
32 days until earnings call
PAHC
Price
$38.81
Change
+$0.77 (+2.02%)
Updated
Sep 26 closing price
Capitalization
1.57B
38 days until earnings call
Interact to see
Advertisement

BHC vs PAHC

Header iconBHC vs PAHC Comparison
Open Charts BHC vs PAHCBanner chart's image
Bausch Health Companies
Price$6.48
Change+$0.02 (+0.31%)
Volume$847.92K
Capitalization2.4B
Phibro Animal Health
Price$38.81
Change+$0.77 (+2.02%)
Volume$193.29K
Capitalization1.57B
BHC vs PAHC Comparison Chart in %
Loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHC vs. PAHC commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a Buy and PAHC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (BHC: $6.48 vs. PAHC: $38.81)
Brand notoriety: BHC: Notable vs. PAHC: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BHC: 29% vs. PAHC: 60%
Market capitalization -- BHC: $2.4B vs. PAHC: $1.57B
BHC [@Pharmaceuticals: Generic] is valued at $2.4B. PAHC’s [@Pharmaceuticals: Generic] market capitalization is $1.57B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHC’s FA Score shows that 0 FA rating(s) are green whilePAHC’s FA Score has 1 green FA rating(s).

  • BHC’s FA Score: 0 green, 5 red.
  • PAHC’s FA Score: 1 green, 4 red.
According to our system of comparison, PAHC is a better buy in the long-term than BHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHC’s TA Score shows that 4 TA indicator(s) are bullish while PAHC’s TA Score has 3 bullish TA indicator(s).

  • BHC’s TA Score: 4 bullish, 6 bearish.
  • PAHC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both BHC and PAHC are a bad buy in the short-term.

Price Growth

BHC (@Pharmaceuticals: Generic) experienced а -3.71% price change this week, while PAHC (@Pharmaceuticals: Generic) price change was -2.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

BHC is expected to report earnings on Oct 30, 2025.

PAHC is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHC($2.4B) has a higher market cap than PAHC($1.57B). PAHC has higher P/E ratio than BHC: PAHC (32.61) vs BHC (24.92). PAHC YTD gains are higher at: 87.269 vs. BHC (-19.603). BHC has higher annual earnings (EBITDA): 3B vs. PAHC (147M). BHC has more cash in the bank: 1.73B vs. PAHC (77M). PAHC has less debt than BHC: PAHC (762M) vs BHC (21.7B). BHC has higher revenues than PAHC: BHC (9.86B) vs PAHC (1.3B).
BHCPAHCBHC / PAHC
Capitalization2.4B1.57B152%
EBITDA3B147M2,041%
Gain YTD-19.60387.269-22%
P/E Ratio24.9232.6176%
Revenue9.86B1.3B761%
Total Cash1.73B77M2,243%
Total Debt21.7B762M2,848%
FUNDAMENTALS RATINGS
BHC vs PAHC: Fundamental Ratings
BHC
PAHC
OUTLOOK RATING
1..100
8470
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
10040
SMR RATING
1..100
10050
PRICE GROWTH RATING
1..100
6337
P/E GROWTH RATING
1..100
36100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (29) in the Pharmaceuticals Major industry is in the same range as BHC (35) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew similarly to BHC’s over the last 12 months.

PAHC's Profit vs Risk Rating (40) in the Pharmaceuticals Major industry is somewhat better than the same rating for BHC (100) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew somewhat faster than BHC’s over the last 12 months.

PAHC's SMR Rating (50) in the Pharmaceuticals Major industry is somewhat better than the same rating for BHC (100) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew somewhat faster than BHC’s over the last 12 months.

PAHC's Price Growth Rating (37) in the Pharmaceuticals Major industry is in the same range as BHC (63) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew similarly to BHC’s over the last 12 months.

BHC's P/E Growth Rating (36) in the Pharmaceuticals Other industry is somewhat better than the same rating for PAHC (100) in the Pharmaceuticals Major industry. This means that BHC’s stock grew somewhat faster than PAHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHCPAHC
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 11 days ago
75%
Bullish Trend 24 days ago
72%
Declines
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDMRX128.481.04
+0.82%
Janus Henderson Enterprise R
PIIFX33.030.23
+0.70%
Victory Pioneer International Equ A
JOHAX27.630.18
+0.66%
JOHCM International Select Investor
KINCX79.370.41
+0.52%
Kinetics Internet Adv C
SIFZX26.73-0.03
-0.11%
Saturna International Z

BHC and

Correlation & Price change

A.I.dvisor tells us that BHC and AMRX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHC and AMRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
+0.31%
AMRX - BHC
33%
Poorly correlated
+1.56%
AMPH - BHC
27%
Poorly correlated
+1.86%
PAHC - BHC
26%
Poorly correlated
+2.02%
DRRX - BHC
26%
Poorly correlated
N/A
SWDCF - BHC
25%
Poorly correlated
N/A
More